Table 2. Model outcomes and cost-effectiveness of mobile unit HIV testing in Cape Town, South Africa.

	Medical facility-based testing	Mobile unit intervention
Total population
Undiscounted life expectancy (months)	449.7	450.7
Discounted life expectancy (months)	249.9	250.4
Discounted per-person costs ($)	3,970	4,070
Incremental cost-effectiveness ratio * ($/YLS)	–	2,400
HIV-infected population
5-year survival (%)	69	73
Undiscounted life expectancy (months)	197.7	211.7
Discounted life expectancy (months)	132.2	140.7
Discounted per-person costs ($)	11,270	12,430
HIV RNA suppressed at 5 years (%)	35	39

^*Incremental cost-effectiveness ratios <1× South African per capita gross domestic product ($8,200) considered very cost-effective based on WHO suggestions [28]. Costs in 2012 US$. Discounted at 3% per year (see methods). YLS: years of life saved.